Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells

Decio Eizirik; Alexander Balhuizen; Nick Devoogdt; Sam Massa; Luc Bouwens; Iris Mathijs

Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells

Decio Eizirik (Uitvinder), Alexander Balhuizen (Uitvinder), Nick Devoogdt (Uitvinder), Sam Massa (Uitvinder), Luc Bouwens (Uitvinder), Iris Mathijs (Uitvinder)

Onderzoeksoutput: Patent

Samenvatting

The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).

Originele taal-2	English
Octrooinummer	US11243214
Status	Published - 2022

Andere bestanden en links

http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=US11243214&F=0

IOF3009: GEAR: Integratie van een multimodale aanpak om de huidige uitdagingen in immuuntherapie aan te pakken (INTEGRAAL)
Lahoutte, T., Devoogdt, N., Keyaerts, M., Van Ginderachter, J., Laoui, D., Raes, G., Breckpot, K., Goyvaerts, C., Raes, G., Bridoux, J. & Baudhuin, H. V.
1/01/20 → 30/06/25
Project: Toegepast

Citeer dit

@misc{fab82eb7f54d4d5795ba2762d2f9f7f1,

title = "Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells",

abstract = "The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).",

author = "Decio Eizirik and Alexander Balhuizen and Nick Devoogdt and Sam Massa and Luc Bouwens and Iris Mathijs",

year = "2022",

language = "English",

type = "Patent",

note = "US11243214",

}

TY - PAT

T1 - Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells

AU - Eizirik, Decio

AU - Balhuizen, Alexander

AU - Devoogdt, Nick

AU - Massa, Sam

AU - Bouwens, Luc

AU - Mathijs, Iris

PY - 2022

Y1 - 2022

N2 - The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).

AB - The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).

UR - http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=US11243214&F=0

M3 - Patent

M1 - US11243214

ER -

Biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells

Samenvatting

Andere bestanden en links

Vingerafdruk

Projecten

IOF3009: GEAR: Integratie van een multimodale aanpak om de huidige uitdagingen in immuuntherapie aan te pakken (INTEGRAAL)

Citeer dit